Alzheimer’s drug, the monoclonal antibody lecanemab, slowed decline in a phase 3 clinical trial, the company said.
admin, , HEALTH & FITNESS, 0
Related Articles
How this Native American tribe fully vaccinated 98% of its citizens
The darkest days of the pandemic stretched through the fall, when ambulances were frequently called to transport tribal members...
FDA clears new Covid boosters to roll out this week
The Food and Drug Administration on Monday greenlighted updated Covid boosters from Pfizer and Moderna. The shots, which are...
Grand Canyon rafters report mystery illnesses on social media
IE 11 is not supported. For an optimal experience visit our site on another browser. July 9, 202602:57 Trump...
Most kids with serious inflammatory illness had mild Covid
Most children with a serious inflammatory illness linked to the coronavirus had initial Covid-19 infections with no symptoms or...
Covid booster shot’s side effects similar to 2nd vaccine dose, CDC study finds
Do booster shots have side effects? Are booster shot side effects worse? A CDC study found that booster shot...
The Mexican state closest to Arizona bans most abortions, setting up a regional void
“The communities most impacted are those who are undocumented, those who live in rural communities with very little resources,...
At what age should you get a colonoscopy?
The recent death of the 48-year-old actor James Van Der Beek is again highlighting how colorectal cancer is increasingly...
The U.S. hasn’t OK’d boosters for those who got the J&J vaccine. But some are getting one anyway.
In early April, Mark Dinan got the single-dose Johnson & Johnson vaccine at a middle school campus near his...
